Accenture Invests in Ryght AI to Accelerate Clinical Research | Ryght AI posted on the topic | LinkedIn
Summary
Accenture Ventures has invested in Ryght AI to support its clinical research platform. The company uses AI Site Twin to help sponsors and CROs identify better trial sites faster and improve feasibility, enrollment forecasting, and activation workflows. The partnership aims to reduce delays in drug development and speed up patient access to new therapies. The announcement is relevant to software readers because it centers on an AI-powered life sciences software company.
Funding
Amount
-
Total raised
Date
November 12, 2025
Announcement date
Investors
-
Lead investors
Company
https://www.ryght.ai/
Funded company
Classifications
industries
HealthTech
applications
Business Intelligence
AskAI Classifications
Labels
SaaS
Healthcare Software
Clinical Trial Management Software
Linked Companies
Refresh Inc.
$1M to $5M
Ryght, Inc.
$1M to $5M